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Summary The papillary cystic variant of the acinic cell adenocarcinoma is a rare
salivary gland tumour, which may behave in an unpredictable manner and exhibit
non-specific histological features. Its diagnosis is important as it may prognosti-
cate for a poorer outcome and it has been reported to universally fatal. We present
a case of this unusual tumour and discuss the diagnostic and management difficul-
ties.c 2005 Elsevier Ltd. All rights reserved.
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8Introduction
Acinic cell adenocarcinoma is an uncommon
tumour of salivary glands with unusual clinical
and histopathological features. The papillary
cystic variant is especially uncommon and its
diagnosis has therapeutic and prognostic signi-
ficance.Case report
A 31 year old Filipino patient was referred with a
lump at the right angle of mandible. There was re-741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reser
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operation for a parotid lump in the Philippines six
years previously and developed a recurrent lump
three months after surgery. She was not aware of
the nature of the procedure or the diagnosis, and
had not been followed up.
Clinical examination revealed a 3 cm well cir-
cumscribed, semi-mobile, painless bilobed mass
at the right angle of the mandible. Facial nerve
function was intact and there was no lymphadenop-
athy or pharyngeal extension.
Her medical records from the Philippines were
obtained and showed she had undergone a lumpec-
tomy for a pleomorphic salivary adenoma (PSA).
The clinical diagnosis of a recurrent PSA was
presumed, and an FNAC and CTS were arranged
prior to surgery.
Cytology showed cells with prominent nucleoli
and nuclear pleomorphism and the possibility of a
second unrelated primary of a mucoepidermoidved.
Papillary cystic variant of the acinic cell adenocarcinoma 147carcinoma or papillary adenocarcinoma was
suggested.
CTS demonstrated a bilobulated enhancing mass
inferior to the parotid gland residue with no evi-
dence of lymphadenopathy (Fig. 1).
At surgery an encapsulated mass was found and
a completion superficial parotidectomy with pres-Figure 1 CTS illustrating the bilobe
Figure 2 Illustrating theervation of the facial nerve was performed. Her
post-operative recovery was uneventful.
Histologically, the tumour was generally well
circumsribed and surrounded by compressed fi-
brous tissue (Fig. 2). There was infiltration and
lymphatic invasion. The parenchyma had a mixed
pattern, and nuclear pleomorphism and mitosesd mass in the right parotid gland.
tumour at low power.
Figure 3 Illustrating characteristic histological features (high power).
148 C. Liew et al.were present. In places there was prominent follic-
ular arrangement comprising multiple cystic lumina
filled with a eosinophilic proteinaceous material
and lined by intercalated duct like cells. Elsewhere
there were large cysts containing papillary projec-
tions with tombstoning of the epithelial lining (Fig.
3). The differential diagnosis of a secondary papil-
lary or follicular thyroid cancer was excluded by
immunostaining for thyroglobulin.
The histological findings were unexpected and
the original specimen slides were obtained for
comparison. This showed a tumour with pleomor-
phic morphology but with features similar to the
second specimen. The original diagnosis was there-
fore revised and a final diagnosis of papillary cystic
variant of acinic cell adenocarcinoma with recur-
rence was concluded.
The patient received post-operative radio-
therapy.Discussion
Acinic cell adenocarcinomas comprise 2.5% of all
salivary gland tumours1 and 12–17% of all salivary
gland cancers,2 of which more than 92% occur in
the parotid gland.3 There is with the exception of
the latter series, a female predilection and the
median age is in the fifth decade.3 The tumour
was originally regarded as benign but Buxton
et al.4 were first to recognise its malignant poten-
tial. It frequently exhibits malignant histological
features and has been reclassified on this basis.
This is consistent with its clinical behaviour.It commonly presents as a painless slow growing
rubbery mass, with fixation and facial nerve
involvement developing in advanced cases. An unu-
sual feature is the occurrence of synchronous or
metachronous tumours in the contralateral gland5
and when this is considered with its other clinical
features it can be misdiagnosed for the commoner
Warthins tumour or PSA.
Histologically it may exhibit cellular pleomor-
phism and differentiation from benign tumours is
essential. The tumours are encapsulated and fea-
tures of capsular invasion are not uncommon.
Nuclear pleomorphism, cellular atypia and mitoses
may be present, and predict a poorer outcome.6
The tumours may be solid or cystic and distinct
morphological growth patterns are seen. These
are described as solid, microcystic, follicular and
papillary cystic.7
Cells resembling serous acinar and intercalated
ducts are typical. The papillary cystic variant
maybe differentiated by the presence of prominent
follicular arrangement, papillary projections, mul-
tiple cystic luminae and tombstoning.
The five year survival rate for acinic cell carcino-
mas is 90% but according to Spiro et al.1 the papil-
lary cystic variant should be conferred significance
because it has a poorer prognosis. In this series
there were no survivors at 10 years.
Prolonged disease progression,8 local recurrence
(35%),3 nodal (16%),3 distant3,8 and haematogenous
spread have been reported and adjuvant radiother-
apy should be considered. Survival in acinic cell
carcinoma is generally better in younger patients
but the outcome is less favourable when patients
present with pain or facial nerve dysfunction.3,8
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the acinic cell adenocarcinoma has significant
implications. It is uncommon. It may not be consid-
ered, or may be misdiagnosed clinically on the
basis of relatively benign characteristics, or when
present bilaterally. It maybe misdiagnosed cytolog-
ically2 and may thus be accorded less significance
and managed conservatively as Warthin’s and PSA
tumours sometimes are, or excised by less radical
methods with narrower margins. Lumpectomy or
extra-capsular dissection procedures may not be
suitable methods.6,8,11 Histologically they may be
misdiagnosed for a benign tumour and this will
clearly have both therapeutic and prognostic con-
sequences. Its diagnosis will also have implications
for the pattern of follow up as very late recur-
rences up to 30 years on have been reported,8–10
and the possible development of a further tumour
in contralateral gland should always be considered.
When local recurrences do occur additional local
surgery can provide good control.8,11
In summary the acinic cell carcinoma is a rare
malignant tumour which may exhibit unusual and
prolonged disease progression and whose prognosis
is dependent on clinical stage and the completion of
excision. Diagnosis maybe difficult as clinical, cyto-
logical and histological features maybe ambivalent.
Prognosis of the papillary-cystic variant has been
reported to be universally fatal within 10 years.Acknowledgments
We would like to thank Dr. Kothari and Dr. Knee,
Consultant Histopathologists at Kingston for kindlyallowing us to use the illustrations of the histology
slides. Professor Speight provided the supplemen-
tary report confirming the diagnosis.References
1. Spiro RH, Huvos AG, Strong EW. Acinic cell carcinoma of
salivary origin: a clinicopathologic study of 67 cases. Cancer
1978;41:924–33.
2. Ali SZ. Acinic cell carcinoma, papillary cystic variant: a
diagnostic dilemma in salivary gland aspiration. Diagn
Cytopathol 2002;27:244–50.
3. Ellis GL, Corio RL. Acinic cell adenocarcinoma. A clinico-
pathologic analysis of 294 cases. Cancer 1983;52(3):542–
49.
4. Buxton RW, Maxwell JH, Branch AJ. Surgical treatment of
epithelial tumors of the parotid gland. Surg Gynecol Obstet
1953;97:401–16.
5. Levin JM, Robinson DW, Lin F. Acinic cell carcinoma:
collective review including bilateral cases. Arch Surg
1975;110:64–8.
6. Perzin KH, LiVolsi VA. Acinic cell carcinomas arising in
salivary gland: a clinicopathologic study. Cancer 1979;
44(4):1434–57.
7. Abrams AM, Coryn J, Schofield HH, Hansen LS. Acinic cell
carcinoma of the major salivary glands: a clinicopathologic
study of 77 cases. Cancer 1965;18:1145–62.
8. Lewis JE, Olsen KD, Weiland LH. Acinic cell carcinoma.
Clinicopathologic review. Cancer 1991;67:172–9.
9. Miki H, Masuda E, Ohata S, Komaki K, Hirokawa M, Uehara
H, et al. Late recurrence of acinic cell carcinoma of the
parotid gland. J Med Invest 1999;46(3–4):213–6.
10. Watson H, Sutherland GR, Diocee M, Sima AAF. Acinic cell
carcinoma metastatic to the brain: case report and ultra-
structural study. Head Neck Surg 1987;10:118–23.
11. Oliveira P, Fonseca I, Soares J. Acinic cell carcinoma of the
salivary glands. A long term follow up study of 15 cases. Eur
J Surg Oncol 1992;18(1):7–15.
